Paul Kim - 26 Jul 2026 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Reporting relationship: CFO and Treasurer
Issuer ticker: FLGT
Reported as of: 26 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jul 2026, 16:32:19 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Paul Kim

Key filing fact

Paul Kim filed Form 4 for Fulgent Genetics, Inc. (FLGT) on 28 Jul 2026.

Key facts

This page summarizes Paul Kim's Form 4 filing for Fulgent Genetics, Inc. (FLGT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Jul 2026, 16:32.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001253820 Primary reporting owner

Kim Paul

Relationship: CFO and Treasurer
Address: C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE
Signature: /s/ Paul Kim
Signature date: 28 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FLGT transaction

Common Stock

Tax liability

Transaction value
Shares: -2,747
Change %: -0.76%
Price: $19.67^*
Shares after: 359,798
Date: 26 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.